The "Patients Before Monopolies Act" aims to regulate pharmacy benefit managers (PBMs), which currently hold significant control over drug pricing and coverage. It identifies PBMs' consolidation and self-preferencing, leading to reduced competition and higher drug costs. The bill prohibits entities from owning both pharmacies and PBMs and introduces remedies for non-compliance, including divestment and penalties. It allows the Federal Trade Commission and the Department of Justice to enforce the law and grants authority for civil actions by federal agencies or state attorneys general. The Act also includes rulemaking authority and reporting requirements to ensure compliance.